United States Female Sexual Dysfunction Market and Competitive Landscape Highlights 2016 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “US
Female Sexual Dysfunction Market and Competitive Landscape Highlights –
2016″ drug pipelines to their offering.
US Female Sexual Dysfunction Market and Competitive Landscape Highlights
– 2016, provides comprehensive insights into Female Sexual Dysfunction
pipeline products, Female Sexual Dysfunction epidemiology, Female Sexual
Dysfunction market valuations and forecast, Female Sexual Dysfunction
products sales and competitive landscape in the US.
The research is classified into nine sections – Female Sexual
Dysfunction overview including etiology, pathophysiology, and diagnosis,
Female Sexual Dysfunction treatment options, Female Sexual Dysfunction
pipeline products, Female Sexual Dysfunction market analysis comprising
of Female Sexual Dysfunction epidemiology, key products marketed for
Female Sexual Dysfunction, market valuations and forecast, products
sales and market shares.
Research Scope:
-
Female Sexual Dysfunction Pipeline: Find out the products in clinical
trials for the treatment of Female Sexual Dysfunction by development
phase 3, phase 2, and phase 1, by pharmacological class and companies
developing the products -
Female Sexual Dysfunction Epidemiology: Find out the number of
patients diagnosed (prevalence) with Female Sexual Dysfunction in the
US -
Female Sexual Dysfunction Products: Identify key products marketed and
prescribed for Female Sexual Dysfunction in the US, including trade
name, molecule name, and company -
Female Sexual Dysfunction Product Sales: Find out the sales revenues
of Female Sexual Dysfunction products, both branded and generics, in
the US -
Female Sexual Dysfunction Market Valuations: Find out the market size
for Female Sexual Dysfunction products in 2015 in the US. Find out how
the market advanced from 2010 and forecast to 2020 -
Female Sexual Dysfunction Products Market Share: Find out the market
shares for key Female Sexual Dysfunction products in the US
Key Topics Covered:
- Disease Overview
- Female Sexual Dysfunction Treatments
- Female Sexual Dysfunction Pipeline
- US Female Sexual Dysfunction Epidemiology
- Marketed Drugs for Female Sexual Dysfunction in US
- US Female Sexual Dysfunction Market Size
- US Female Sexual Dysfunction Products Sales
- US Female Sexual Dysfunction Market Competitive Landscape
- US Female Sexual Dysfunction Market Forecast
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/xdnk74/us_female_sexual
Contacts
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related
Topics: Women’s
Health, Sexual
and Reproductive Health Drugs